Jane Lowe Meisel, MD (@jane_meisel) 's Twitter Profile
Jane Lowe Meisel, MD

@jane_meisel

Medical oncologist @WinshipAtEmory specializing in treatment of and research to improve the care of patients with breast and gynecologic cancers. #bcsm #gynsm

ID: 4351007123

linkhttps://winshipcancer.emory.edu/bios/faculty/meisel-jane-l.html calendar_today02-12-2015 13:38:51

255 Tweet

1,1K Takipçi

219 Takip Edilen

Total Health | Oncology 📖🔬 (@totalhealthconf) 's Twitter Profile Photo

Parents & guardians across the nation are faced with new, difficult choices around schooling in the Fall. Our panel of oncologists/parents and a pediatrician discuss the factors to consider. Join the conversation on Mon. Sept 7 at 8pm EST. Roohi Ismail-Khan, MD, MSc Heloisa Soares MD Jane Lowe Meisel, MD

Jane Lowe Meisel, MD (@jane_meisel) 's Twitter Profile Photo

Along w/R. Donald Harvey PharmD and Van and Lis, it was great to meet with David Perdue Senator Kelly Loeffler and Rep. Hank Johnson to discuss COVID-19 relief, access to #clinicaltrials, #telehealth and step therapy. Critical issues for Georgians and for all Americans. #ASCOAdvocacySummit

Jane Lowe Meisel, MD (@jane_meisel) 's Twitter Profile Photo

The summers I spent GradyHealth seem like forever ago, but the lessons I learned there about compassion, inequality, real-world medicine, and access to care are still so pivotal today. So glad to be back in #ATL as an MD today. Winship Cancer Institute of Emory University

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Winship experts leading advancements in cancer detection and innovative therapies share their insights for Atlanta Jewish Times about a Jewish genetic predisposition to certain cancers such as breast and ovarian cancer. atlantajewishtimes.timesofisrael.com/is-there-a-jew…

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Winship breast oncologist Jane Meisel, MD, has been appointed to represent American Society of Clinical Oncology (ASCO) on the board of directors of the National Accreditation Program for Breast Centers, starting Oct. 1, 2021. Congratulations Jane Lowe Meisel, MD!

Winship breast oncologist Jane Meisel, MD, has been appointed to represent American Society of Clinical Oncology (<a href="/ASCO/">ASCO</a>) on the board of directors of the National Accreditation Program for Breast Centers, starting Oct. 1, 2021. Congratulations <a href="/jane_meisel/">Jane Lowe Meisel, MD</a>!
Jane Lowe Meisel, MD (@jane_meisel) 's Twitter Profile Photo

OlympiA to be presented this weekend ASCO and published in NEJM today. Exciting results that highlight the importance of genetic testing not just for cancer prevention but for treatment. #bcsm nejm.org/doi/full/10.10…

Jane Lowe Meisel, MD (@jane_meisel) 's Twitter Profile Photo

Honored and excited to chair CURE’s Educated Patient MBC Summit on Saturday, including talks and panels with many of my Winship Cancer Institute of Emory University colleagues and some incredible #bcsm patient advocates!

Jane Lowe Meisel, MD (@jane_meisel) 's Twitter Profile Photo

Excited to be heading to St. Louis today to discuss #mbc at the #ASCO22 Direct St. Louis Conference. So many exciting abstracts to discuss this year. Luckily I’m a fast talker 😉! 💞✈️💪🏻 Total Health | Oncology 📖🔬

#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

📢We’re leaving 2022 with a 💥#WomenInOncology 💥 on #TumorBoardTuesday! 🎄Jane Lowe Meisel, MD Dionisia Quiroga, DO, PhD, FASCO take us through 2L tx of #BRCA mutation Join us!👇🏽 📱Weigh in how YOU’D treat 🧾Bring citations 📊check polls 🔁RT 👩🏽‍🏫tag peers👩🏻‍🏫 Mike Pishvaian Johnathan Ebben MD, PhD #Tweetorial #MedTwitter

Dionisia Quiroga, DO, PhD (@quirogad) 's Twitter Profile Photo

#TumorBoardTuesday Jane Lowe Meisel, MD Mike Pishvaian Johnathan Ebben MD, PhD Jasmine Sukumar MD @DrGattiMays 2/17 #TumorBoardTuesday #bcsm 🤨 Poll: What percent of all people diagnosed with #BreastCancer carry a germline BRCA 1 and/or 2 mutation? 🤔Are there features that might make you more likely to suspect a patient is a mutation carrier? Daniel Stover, MD, FASCO Sagar Sardesai OncoAlert